HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER
European Patent
12841601.3
Filed on 2012-10-18
12841601.3
Filed on 2012-10-18
HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER
Canada
2852682
Filed on 2012-10-18
2852682
Filed on 2012-10-18
HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER
Australia
2012326105
Filed on 2012-10-18
2012326105
Filed on 2012-10-18
Defensin-Antigen Fusion Proteins
US Application 14/268,949
Filed on 2014-05-02
Filed on 2014-05-02
Genetic Marker For Predicting Prognosis In Patients Infected With Hepatitis C Virus
US Application 14/349,395
Filed on 2014-04-03
Filed on 2014-04-03
YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF
Singapore
201400975-7
Filed on 2012-08-17
201400975-7
Filed on 2012-08-17
YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF
Mexico
MX/a/2014/001717
Filed on 2012-08-17
MX/a/2014/001717
Filed on 2012-08-17
YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF
Israel
230863
Filed on 2014-02-06
230863
Filed on 2014-02-06
YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF
China
201280051154.2
Filed on 2012-08-17
201280051154.2
Filed on 2012-08-17
YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF
Canada
2844500
Filed on 2012-08-17
2844500
Filed on 2012-08-17